The critical role of RPLP2 in DLBCL progression propels us to further explore the possibility of targeting RPLP2, specifically with highly sensitive chemicals, to improve the prognosis of DLBCL patients. Here, RPLP2 is linked to diffuse large B-cell lymphoma.